This company has been marked as potentially delisted and may not be actively trading. (BIOA) (BIOA) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOwnershipTrendsBuy This Stock BIOA vs. SBTX, ETHZ, NLTX, AVTE, VIRI, WHWK, SPRB, LITS, ELYM, and AADIShould you be buying (BIOA) stock or one of its competitors? The main competitors of (BIOA) include Silverback Therapeutics (SBTX), Flag Ship Acquisition (ETHZ), Neoleukin Therapeutics (NLTX), Aerovate Therapeutics (AVTE), Virios Therapeutics (VIRI), Whitehawk Therapeutics (WHWK), Spruce Biosciences (SPRB), Lite Strategy (LITS), Eliem Therapeutics (ELYM), and Aadi Bioscience (AADI). (BIOA) vs. Its Competitors Silverback Therapeutics Flag Ship Acquisition Neoleukin Therapeutics Aerovate Therapeutics Virios Therapeutics Whitehawk Therapeutics Spruce Biosciences Lite Strategy Eliem Therapeutics Aadi Bioscience Silverback Therapeutics (NASDAQ:SBTX) and (BIOA) (NYSE:BIOA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, institutional ownership, risk, profitability and earnings. Does the media refer more to SBTX or BIOA? In the previous week, (BIOA) had 2 more articles in the media than Silverback Therapeutics. MarketBeat recorded 2 mentions for (BIOA) and 0 mentions for Silverback Therapeutics. Silverback Therapeutics' average media sentiment score of 0.00 equaled (BIOA)'saverage media sentiment score. Company Overall Sentiment Silverback Therapeutics Neutral (BIOA) Neutral Is SBTX or BIOA more profitable? (BIOA)'s return on equity of 0.00% beat Silverback Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Silverback TherapeuticsN/A -29.62% -28.20% (BIOA) N/A N/A N/A Do analysts recommend SBTX or BIOA? (BIOA) has a consensus price target of $5.67, indicating a potential downside of 0.41%. Given (BIOA)'s stronger consensus rating and higher probable upside, analysts clearly believe (BIOA) is more favorable than Silverback Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Silverback Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00(BIOA) 1 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.75 Which has higher valuation & earnings, SBTX or BIOA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSilverback TherapeuticsN/AN/A-$89.48M-$2.42-4.40(BIOA)N/AN/AN/AN/AN/A Do insiders & institutionals believe in SBTX or BIOA? 74.9% of Silverback Therapeutics shares are owned by institutional investors. 34.4% of Silverback Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Summary(BIOA) beats Silverback Therapeutics on 5 of the 7 factors compared between the two stocks. Get (BIOA) News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIOA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIOA vs. The Competition Export to ExcelMetric(BIOA)Pharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$203.99M$1.06B$6.12B$21.89BDividend YieldN/A4.84%5.73%3.62%P/E RatioN/A1.2585.3330.12Price / SalesN/A31.47601.99108.95Price / CashN/A17.6437.4624.26Price / BookN/A7.6612.564.70Net IncomeN/A-$7.71M$3.32B$1.01B (BIOA) Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOA(BIOA)N/A$5.69+3.3%$5.67-0.4%-77.5%$203.99MN/A0.00N/ASBTXSilverback TherapeuticsN/A$10.93-3.4%N/A-30.0%$394.11MN/A-4.5283High Trading VolumeETHZFlag Ship AcquisitionN/A$1.92-3.0%N/AN/A$325.57MN/A-0.137News CoverageStock SplitGap DownNLTXNeoleukin TherapeuticsN/A$31.62+4.7%N/A-33.6%$297.17MN/A-10.1790High Trading VolumeAVTEAerovate TherapeuticsN/A$9.09+0.1%N/A-87.6%$263.47MN/A-3.0420News CoverageHigh Trading VolumeVIRIVirios TherapeuticsN/A$6.18+15.1%N/A+70.5%$119.01MN/A-22.895News CoverageWHWKWhitehawk Therapeutics1.0337 of 5 stars$1.97-3.4%N/AN/A$96.14M$25.98M-32.8321High Trading VolumeSPRBSpruce Biosciences0.7338 of 5 stars$176.91+11.3%$131.25-25.8%+353.9%$89.31M$4.91M-2.0520News CoverageAnalyst ForecastGap DownLITSLite StrategyN/A$2.19+1.9%N/AN/A$76.66M$65.30M-0.46100ELYMEliem TherapeuticsN/A$2.00+11.1%N/A-65.4%$59.50MN/A-3.779Gap DownAADIAadi BioscienceN/A$2.02-6.9%N/A-7.5%$49.89M$25.07M-0.8940 Related Companies and Tools Related Companies Silverback Therapeutics Alternatives Flag Ship Acquisition Alternatives Neoleukin Therapeutics Alternatives Aerovate Therapeutics Alternatives Virios Therapeutics Alternatives Whitehawk Therapeutics Alternatives Spruce Biosciences Alternatives Lite Strategy Alternatives Eliem Therapeutics Alternatives Aadi Bioscience Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BIOA) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (BIOA) Please log in to your account or sign up in order to add this asset to your watchlist. Share (BIOA) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
